SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes

Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subtypes, which have differences in prognosis and sens...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Madera, Santiago, Chiauzzi, Violeta A, Chervo, María F, Pereyra, Matías G, Venturutti, Leandro, Deamicis, Agustina Roldán, Dupont, Agustina, Guzmán, Pablo, Roa, Juan C, Cenciarini, Mauro E, Barchuk, Sabrina, Figurelli, Silvina, Vecchia, Daniel Lopez Della, Ares, Sandra, Proietti, Cecilia J, Deza, Ernesto Gil, Gercovich, Felipe G, Schillaci, Roxana, Elizalde, Patricia V, Cordo Russo, Rosalia I
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Tumor Biology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1037
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы